Materials & Resources » Mining, Metals & Minerals | Zenotech Laboratories Ltd.

Zenotech Laboratories Ltd. | Income Statement

Fiscal year is April-March. All values INR Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
27,557.00
40,767.00
20,598.00
22,542.00
111,442.00
Cost of Goods Sold (COGS) incl. D&A
184,845.00
131,678.00
101,960.00
134,969.00
97,675.00
Gross Income
157,288.00
90,911.00
81,362.00
112,427.00
13,767.00
SG&A Expense
37,239.00
41,880.00
17,893.00
13,498.00
131,474.00
EBIT
182,240.00
239,604.00
-
142,394.00
117,707.00
Unusual Expense
-
1,077.00
331.00
18,349.00
-
Non Operating Income/Expense
3,119.00
1,317.00
2,158.00
271.00
23,691.00
Interest Expense
46,864.00
66,525.00
75,460.00
75,139.00
24,494.00
Pretax Income
228,554.00
304,143.00
191,373.00
198,687.00
118,510.00
Consolidated Net Income
228,554.00
304,143.00
191,373.00
198,687.00
118,510.00
Net Income
228,554.00
304,143.00
191,373.00
198,687.00
118,510.00
Net Income After Extraordinaries
228,554.00
304,143.00
191,373.00
198,687.00
118,510.00
Net Income Available to Common
228,554.00
304,143.00
191,373.00
198,687.00
118,510.00
EPS (Basic)
6.30
8.38
5.28
5.48
2.24
Basic Shares Outstanding
36,274.00
36,274.00
36,274.00
36,274.00
-
EPS (Diluted)
6.30
8.38
5.28
5.48
-
Diluted Shares Outstanding
36,275.90
36,275.90
36,274.00
36,274.00
-
EBITDA
146,679.00
199,041.00
76,522.00
103,653.00
78,676.00
Other Operating Expense
12,287.00
106,813.00
16,890.00
16,469.00
-
Non-Operating Interest Income
3,669.00
2,226.00
2,059.00
226.00
-

About Zenotech Laboratories

View Profile
Address
Survey No. 250-252
Hyderabad TS 500078
India
Employees -
Website http://www.zenotechlab.com
Updated 09/14/2018
Zenotech Laboratories Ltd. is a pharmaceuticals manufacturing company, which engages in the manufacture and marketing of pharmaceuticals products. Its injectable product portfolio serves niche therapy areas like oncology and anesthesiology. The company was founded on June 15, 1989 and is headquartered in Hyderabad, India.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.